Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.

Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.

OBJECTIVE: To compare the efficacy and safety of cholestyramine, an anion exchange resin, and pravastatin, a new hydrophilic specific inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, in the treatment of heterozygous familial hypercholesterolaemia. DESIGN: Double blind, double dummy, pla...

Full description

Bibliographic Details
Main Authors:	Betteridge, D, Bhatnager, D, Bing, R, Durrington, P, Evans, G, Flax, H, Jay, R, Lewis-Barned, N, Mann, J, Matthews, DR
Format:	Journal article
Language:	English
Published:	1992

Similar Items

Effects of pravastatin and cholestyramine on products of the mevalonate pathway in familial hypercholesterolemia.
by: PG Elmberger, et al.
Published: (1991-06-01)

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.
by: Humphries, SE, et al.
Published: (2006)

The utility of DNA-based testing in patients with familial hypercholesterolaemia in the UK
by: Humphries, SE, et al.
Published: (2005)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
by: Neil, H, et al.
Published: (2004)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
by: Neil, H, et al.
Published: (2003)

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, H, et al.
Published: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
by: Neil, A, et al.
Published: (2003)

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group.
by: Neil, H, et al.
Published: (1999)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, H, et al.
Published: (2005)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
by: Neil, A, et al.
Published: (2008)

Extraction of bile acids from rat feces containing cholestyramine
by: J.D. Manes, et al.
Published: (1971-05-01)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.
by: Neil, A, et al.
Published: (2008)

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study.
by: Tonkin, A, et al.
Published: (2000)

Pravastatin therapy and the risk of stroke.
by: White, H, et al.
Published: (2000)

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
by: Reid, I, et al.
Published: (2001)

Sodium cholate sorption on N-octadecylpectinamide in comparison with cholestyramine
by: Andriy Synytsya, et al.
Published: (2007-02-01)

Cholestyramine Use for Rapid Reversion to Euthyroid States in Patients with Thyrotoxicosis
by: Jeonghoon Ha, et al.
Published: (2016-09-01)

Familial hypercholesterolaemia.
by: Gill, P, et al.
Published: (2012)

Bile acids and lipids in isolated rat hepatocytes: content, synthesis, and release, as affected by cholestyramine treatment of the donor rats
by: H J Kempen, et al.
Published: (1982-08-01)

Randomized controlled trial of cholestyramine and hydrotalcite to eliminate bile for capsule endoscopy
by: Chen Hong-Bin, et al.
Published: (2016-01-01)

Sex-associated effect of <it>CETP </it>and <it>LPL </it>polymorphisms on postprandial lipids in familial hypercholesterolaemia
by: Marvaki Christina, et al.
Published: (2009-06-01)

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
by: Minhas, R, et al.
Published: (2009)

Additive hypocholesterolemic effect of psyllium and cholestyramine in the hamster: influence on fecal sterol and bile acid profiles
by: B P Daggy, et al.
Published: (1997-03-01)

Statins and familial hypercholesterolaemia.
by: Neil, A, et al.
Published: (2009)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
by: Marks, D, et al.
Published: (2000)

Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study.
by: Neil, H, et al.
Published: (2000)

Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial
by: Reid, I, et al.
Published: (2001)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
by: Seed, M, et al.
Published: (2009)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
by: Seed, M, et al.
Published: (2009)

Relationship between Dietary Habits and Control of Lipid Profiles in Patients with Dyslipidemia Using Pravastatin
by: Seo Young Kang, et al.
Published: (2021-10-01)

Guidelines for lowering lipids to reduce coronary artery disease risk: A comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals - Discussion
by: Davidson, M, et al.
Published: (2003)

Refractory Graves' Disease Successfully Cured by Adjunctive Cholestyramine and Subsequent Total Thyroidectomy
by: Yeoree Yang, et al.
Published: (2015-12-01)

Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment
by: TE Strandberg, et al.
Published: (1990-09-01)

Cholesteryl ester turnover in human plasma lipoproteins during cholestyramine and clofibrate therapy
by: Dewitt S. Goodman, et al.
Published: (1970-05-01)

Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction.
by: LB Nguyen, et al.
Published: (1991-12-01)

Mevinolin and cholestyramine inhibit the direct synthesis of low density lipoprotein apolipoprotein B in miniature pigs.
by: M W Huff, et al.
Published: (1985-10-01)

The possibility of using pravastatin in plant protection
by: Kartashov M.I.
Published: (2014-12-01)

An investigation into any correlation between Single Nucleotide Polymorphism (SNP) score and Welsh score in Familial Hypercholesterolaemia patients and those with polygenic hypercholesterolaemia
by: J. Webster, et al.
Published: (2022-10-01)

EASILY MISSED? Familial hypercholesterolaemia
by: Gill, P, et al.
Published: (2012)

Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials
by: Edwards, J, et al.
Published: (2003)